You have 9 free searches left this month | for more free features.

adult acute basophilic leukemia

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Adult Acute Basophilic Leukemia, Adult Acute Eosinophilic Leukemia, Adult Acute Megakaryoblastic Leukemia (M7) Trial in Atlanta,

Terminated
  • Adult Acute Basophilic Leukemia
  • +16 more
  • eltrombopag olamine
  • standard follow-up care
  • Atlanta, Georgia
  • +1 more
Jul 20, 2022

Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Basophilic Leukemia, Adult

Active, not recruiting
  • Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome
  • +18 more
  • eltrombopag olamine
  • Cleveland, Ohio
    Case Comprehensive Cancer Center
Nov 29, 2021

Acute Myeloid Leukemia, Adult Acute Basophilic Leukemia, Adult Acute Monoblastic Leukemia Trial in United States (Cytarabine,

Active, not recruiting
  • Acute Myeloid Leukemia
  • +9 more
  • Brewer, Maine
  • +8 more
Jun 18, 2021

Acute Myeloid Leukemia Trial (ABBV-787)

Not yet recruiting
  • Acute Myeloid Leukemia
  • (no location specified)
Sep 29, 2023

B-cell Acute Lymphoblastic Leukemia Trial (HY004, Cyclophosphamide, Fludarabine Phosphate)

Not yet recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • HY004
  • +2 more
  • (no location specified)
Aug 18, 2023

Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

Recruiting
  • Burkitt Lymphoma
  • +2 more
  • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
  • Zhuhai, Guangdong, China
    The Fifth Affiliated Hospital of Sun Yat-sen University
Sep 25, 2023

Relapsed Adult ALL, Relapsed Adult AML Trial in Changchun (Plerixafor)

Active, not recruiting
  • Relapsed Adult ALL
  • Relapsed Adult AML
  • Changchun, Jilin, China
    First Hospital of Jilin University
Nov 19, 2023

ALL, Adult, AML, Adult Trial (BN104)

Not yet recruiting
  • ALL, Adult
  • AML, Adult
  • (no location specified)
Sep 19, 2023

Patients With Acute Myeloid Leukemia

Recruiting
  • Acute Myeloid Leukemia, Adult
    • Freiburg, CA, Germany
      Medical Center- University of Freiburg
    Aug 4, 2023

    Acute Lymphoid Leukemia, Minimal Residual Disease, Gene Abnormality Trial in São Paulo (Prednisone, Vincristin, Daunorubicin)

    Recruiting
    • Acute Lymphoid Leukemia
    • +3 more
    • São Paulo, SP, Brazil
      Instituto do Cancer do Estado de Sao Paulo
    Jul 24, 2023

    Oral Venetoclax Tablets + Subcutaneously Injected Azacitidine in

    Not yet recruiting
    • Acute Myeloid Leukemia
      • (no location specified)
      Sep 22, 2023

      Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia Trial in Tianjin (Vincristine, Daunorubicin, Cyclophosphamide)

      Recruiting
      • Philadelphia Chromosome-Negative Acute Lymphoblastic Leukemia
      • Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Dec 13, 2022

      Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b) Trial

      Completed
      • Adult Acute Megakaryoblastic Leukemia (M7)
      • +13 more
      • Philadelphia, Pennsylvania
        Thomas Jefferson University
      Feb 2, 2023

      Acute Myeloid Leukemia (AML) Trial in Austria, Italy, Spain (Ivosidenib Oral Tablet, Azacitidine)

      Not yet recruiting
      • Acute Myeloid Leukemia (AML)
      • Vienna, Austria
      • +3 more
      Jun 8, 2023

      Acute Myeloid Leukemia Trial in Aurora (Azacitidine, Venetoclax)

      Recruiting
      • Acute Myeloid Leukemia
      • Aurora, Colorado
        Universtiy of Colorado Hospital
      Aug 22, 2022

      Myeloid Malignancies, Acute Lymphocytic Leukemia, Lymphomas Trial (KT-253)

      Not yet recruiting
      • Myeloid Malignancies
      • +3 more
      • (no location specified)
      Mar 22, 2023

      Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome

      Active, not recruiting
      • Acute Lymphoblastic Leukemia
      • +15 more
      • Laboratory Biomarker Analysis
      • +3 more
      • Chicago, Illinois
      • +2 more
      Jan 12, 2023

      B Acute Lymphoblastic Leukemia, Ph-Negative ALL, High Risk Acute Lymphoblastic Leukemia Trial (Azacitidine Injection,

      Not yet recruiting
      • B Acute Lymphoblastic Leukemia
      • +2 more
      • Azacitidine Injection
      • +2 more
      • (no location specified)
      Oct 15, 2023

      MDS, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic Trial in Newcastle (Subcutaneous azacitidine, Oral

      Not yet recruiting
      • Myelodysplastic Syndromes
      • +3 more
      • Subcutaneous azacitidine
      • Oral decitabine/cedazuridine
      • Newcastle, New South Wales, Australia
        Calvary Mater Newcastle
      May 29, 2023

      Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic

      Completed
      • Adult Acute Megakaryoblastic Leukemia (M7)
      • +15 more
      • trebananib
      • +3 more
      • Buffalo, New York
      • +1 more
      Sep 8, 2022

      Determining the Mechanisms of Loss of CAR T Cell Persistence

      Not yet recruiting
      • Acute Lymphoblastic Leukemia With Failed Remission
      • +4 more
        • (no location specified)
        Mar 29, 2023

        Acute Myeloid Leukemia Trial in Suzhou (Venetoclax Oral Tablet, Daunorubicin)

        Recruiting
        • Acute Myeloid Leukemia
        • Suzhou, Jiangsu, China
        • +1 more
        Jul 3, 2023

        Venetoclax Plasma Concentration and Remission in Acute Myeloid

        Not yet recruiting
        • Adult Acute Myeloid Leukemia
        • Blood sampling for venetoclax drug dosage (venous puncture)
        • (no location specified)
        Sep 13, 2023

        Clinical Significance of Occult Central Nervous System

        Recruiting
        • Acute Lymphoblastic Leukemia
        • cerebrospinal fluids exams
        • Roma, RM, Italy
          Tor Vergata University
        Mar 17, 2023